HighTower Advisors, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1462245 CHICAGO, IL

Position in BCRX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$200,230

+$15,552 QoQ

Shares Held

20,023

+3.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#206

of 316 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $47,963,007 across 28 Drug Manufacturers - Specialty & Generic names. BCRX ranks #24 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	253,412	$18,210,186
2	TEVA	Teva Pharmaceutical Industries Ltd	205,600	$6,965,728
3	INDV	Indivior Pharmaceuticals, Inc.	83,088	$3,409,100
4	UTHR	UNITED THERAPEUTICS Corp	4,008	$2,171,654
5	VTRS	Viatris Inc	130,959	$2,079,628
6	ETON	Eton Pharmaceuticals, Inc.	52,907	$1,915,233
7	TRLV	Trulieve Cannabis Corp.	156,492	$1,538,316
8	TAK	Takeda Pharmaceutical Co Ltd	95,466	$1,530,319

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$200,230	20,023	+3.2%	Shares	Sole	2026-08-05
2026-03-31	$184,678	19,399	+7.6%	Shares	Sole	2026-05-05
2025-12-31	$140,634	18,030	+5.4%	Shares	Sole	2026-02-06
2025-09-30	$129,789	17,100	+0.6%	Shares	Sole	2025-11-07
2025-06-30	$152,320	17,000	-0.4%	Shares	Sole	2025-08-11
2025-03-31	$127,957	17,061	-3.1%	Shares	Sole	2025-05-13
2024-12-31	$132,352	17,600	-7.7%	Shares	Sole	2025-02-07
2024-09-30	$144,848	19,059	-5.4%	Shares	Sole	2024-11-14
2024-06-30	$124,527	20,150	+11.0%	Shares	Sole	2024-08-13
2024-03-31	$92,202	18,150	0.0%	Shares	Sole	2024-05-06
2023-12-31	$108,718	18,150	+1.1%	Shares	Sole	2024-02-12
2023-09-30	$127,078	17,949	-3.5%	Shares	Sole	2023-11-08
2023-06-30	$130,944	18,600	-27.7%	Shares	Sole	2023-08-14
2020-12-31	$191,658	25,726	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.